Pre-exposure prophylaxis (PrEP) is one of the best interventions we have for preventing and stopping HIV transmission, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Pre-exposure prophylaxis (PrEP) is one of the best interventions we have for preventing and stopping HIV transmission, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Transcript
With the Trump administration's plan to end the HIV epidemic by 2030, a crucial part of this will be stopping new infections. So, how important will access and adherence to PrEP be for this?
I think not only PrEP [pre-exposure prophylaxis], but also post-exposure prophylaxis is really important. One of the best parts of my job is that I get to work on the post-exposure prophylaxis, the PEP hotline that we have in the healthcare system that I work for, where if a patient’s been exposed, usually through sexual exposure, they’ll call the hotline and let us know and we’ll give them the HIV medications right away to stop them from converting to HIV.
That’s one example of what’s required to really meet our country’s goals of stopping the transmission of HIV in the timeframe that we’ve outlined. So, you not only need something like a post-exposure prophylaxis, but you absolutely need pre-exposure prophylaxis. One of the teenage patients that I work with, and it was devastating to hear this, he was infected the very first time he had a sexual experience with someone. It was after he got infected with HIV that he then found out about PrEP, and he said, “I wish someone had told me about this. I wish I knew about this.” And what we’re finding is that PrEP is really great for some populations. In terms of being great I mean have made it into certain populations in terms of being utilized. But it hasn’t made it into others like black or Latino men who have sex with men, who are still struggling to really have access.
PrEP is one of the best interventions we have for preventing and stopping HIV transmission, so we as clinicians and public health experts and health systems have to do a much better job of really thinking about PrEP use holistically and I would say that we still have a ways to go. But I think overall, everyone’s realizing there’s so much potential and if we can sort of organize ourselves, there’s a lot of very good work we can do with PrEP and other modalities like PEP.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More